myrtenol profile

Myrtenol is a monoterpene alcohol found in numerous plants, including rosemary, myrtle, and eucalyptus. It is a colorless liquid with a characteristic camphoraceous odor. Its synthesis can be achieved through various methods, including the dehydration of borneol and the reduction of myrtenal. Myrtenol has demonstrated biological activities such as antimicrobial, antioxidant, and anti-inflammatory effects. Research suggests that it may exhibit potential benefits for skin health, wound healing, and neurological disorders. Its unique structure and biological activities make it a subject of ongoing research, particularly in the fields of medicine, cosmetics, and flavoring. '

myrtenol: fragrance ingredient; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

ID Source	ID
PubMed CID	10582
CHEMBL ID	443408
SCHEMBL ID	155709
MeSH ID	M0528485

Synonym
bicyclo[3.1.1]hept-2-ene-2-methanol, 6,6-dimethyl-
bicyclo[3.1.1]hept-2-ene-2-methanol, 6,6-dimethyl-, (1s)-
6,6-dimethyl-2-oxymethylbicyclo[3.1.1]hept-2-ene
(+/-)-myrtenol
alpha-pinene-10-ol
6,6-dimethyl-2-(hydroxymethyl)bicyclo[3.1.1]hept-2-ene
6,6-dimethylbicyclo[3.1.1]hept-2-ene-2-methanol
nsc-408846
pinen-10-ol, l-2-
nsc408846
myrtenol
2-pinen-10-ol
515-00-4
6,6-dimethylbicyclo(3.1.1)hept-2-ene-2-methanol
LMPR0102120022
( )-myrtenol
bicyclo(3.1.1)hept-2-ene-2-methanol, 6,6-dimethyl-, (1s)-
bicyclo(3.1.1)hept-2-ene-2-methanol, 6,6-dimethyl-
BMSE000555
2-hydroxymethyl-6,6-dimethylbicyclo(3.1.1)hept-2-ene
(-)-pin-2-ene-10-ol
6,6-dimethyl-2-hydroxymethylbicyclo(3.1.1)hept-2-ene
CHEMBL443408
AKOS000120271
nsc 408846
fema no. 3439
einecs 208-193-5
(1r)-6,6-dimethylbicyclo[3.1.1]hept-2-ene-2-methanol
(1r)-2-pinen-10-ol
(1r)-(-)-myrtenol
SCHEMBL155709
rac-(6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)methanol
(-)-myrtenol, 97
(6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)methanol #
myrtenol (.alpha.-pinene-10-ol)
6,6-dimethyl-bicyclo[3,1,1]hept-2-ene-2-methanol
6,6-dimethyl-2-oxymethlybicyclo[1.1.3]-hept-2-ene (myrtenol)
J-012851
FT-0774002
DTXSID00862089
(6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)methanol
6,6-dimethyl-bicyclo[3.1.1]hept-2-ene-2-methanol
1056567-07-7
(6,6-dimethyl-2-bicyclo[3.1.1]hept-2-enyl)methanol
Q15425810

Excerpt	Reference	Relevance
"Myrtenol is a monoterpene with multiple pharmacological activities. "	( Myrtenol protects against myocardial ischemia-reperfusion injury through antioxidant and anti-apoptotic dependent mechanisms. Albuquerque-Júnior, RLC; Britto, RM; de Almeida, GKM; de Sá, LA; Dos Santos, FSM; Guatimosim, S; Jesus, ICG; Lauton-Santos, S; Mesquita, TRR; Miguel-Dos-Santos, R; Pereira-Filho, RN; Quintans-Júnior, LJ; Santos, PHD; Silva-Neto, JAD; Souza, DS; Vasconcelos, CML, 2018)	3.37
"(-)-Myrtenol is a natural fragrance monoterpenoid structurally related to α-pinene found in diverse plant essential oils. "	( Gastroprotective effect of (-)-myrtenol against ethanol-induced acute gastric lesions: possible mechanisms. Almeida Santos, F; Braga, MA; da Silva, FV; de Sousa, DP; Fernandes, Hde B; Nunes, PI; Oliveira, IS; Oliveira, Rde C; Rao, VS; Viana, AF; Viana, Dde A, 2016)	1.28

Excerpt	Reference	Relevance
"Myrtenol has gained wide interest because of its pharmacological profiles, mainly for treatment of chronic diseases. "	( Characterization of β-cyclodextrin/myrtenol complex and its protective effect against nociceptive behavior and cognitive impairment in a chronic musculoskeletal pain model. Beserra Filho, JIA; Bezerra, DP; da Silva, SP; de Carvalho Neto, AG; de Carvalho, YMBG; de Souza Araújo, AA; de Souza Siqueira Quintans, J; Dos Anjos, KS; Dos Santos, BL; Heimfarth, L; Marreto, RN; Melo Coutinho, HD; Nunes, PS; Quintans-Júnior, LJ; Ribeiro, AM; Scotti, L; Scotti, MT; Serafini, MR, 2020)	2.28
"Myrtenol has protective effects on myocardial I/R injury through antioxidant and anti-apoptotic effects."	( Myrtenol improves brain damage and promotes angiogenesis in rats with cerebral infarction by activating the ERK1/2 signalling pathway. Cai, J; Huang, S; Tan, Z; Tian, Y; Wang, Z, 2021)	2.79

Excerpt	Reference	Relevance
"Myrtenol treatment notably decreased the status of blood glucose and lipid profile and improved the HDL in the GDM rats."	( Myrtenol alleviates oxidative stress and inflammation in diabetic pregnant rats via TLR4/MyD88/NF-κB signaling pathway. Chen, G; Liu, M; Qiu, S; Xuemei, L, 2021)	2.79

Pathway	Proteins	Compounds
Limonene and Pinene Degradation	2	10

Assay ID	Title	Year	Journal	Article
AID344008	Antiproliferative activity against human PC3 cells assessed as reduction of cell viability at 400 uM after 72 hrs by WST-1 assay	2008	Bioorganic & medicinal chemistry letters, Jul-15, Volume: 18, Issue:14	Synthesis of phosphatidylated-monoterpene alcohols catalyzed by phospholipase D and their antiproliferative effects on human cancer cells.
AID344010	Antiproliferative activity against human HL60 cells at 400 uM by WST-1 assay	2008	Bioorganic & medicinal chemistry letters, Jul-15, Volume: 18, Issue:14	Synthesis of phosphatidylated-monoterpene alcohols catalyzed by phospholipase D and their antiproliferative effects on human cancer cells.
AID344009	Antiproliferative activity against human HL60 cells by WST-1 assay	2008	Bioorganic & medicinal chemistry letters, Jul-15, Volume: 18, Issue:14	Synthesis of phosphatidylated-monoterpene alcohols catalyzed by phospholipase D and their antiproliferative effects on human cancer cells.
AID1066527	Antiinflammatory activity against human primary chondrocytes assessed as inhibition of IL-1beta-induced NO production at 10 to 25 ug/ml after 30 mins by Griess method	2014	Journal of natural products, Feb-28, Volume: 77, Issue:2	Anti-inflammatory and chondroprotective activity of (+)-α-pinene: structural and enantiomeric selectivity.
AID344007	Antiproliferative activity against human PC3 cells assessed as reduction of cell viability after 72 hrs by WST-1 assay relative to control	2008	Bioorganic & medicinal chemistry letters, Jul-15, Volume: 18, Issue:14	Synthesis of phosphatidylated-monoterpene alcohols catalyzed by phospholipase D and their antiproliferative effects on human cancer cells.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (11.76)	29.6817
2010's	18 (52.94)	24.3611
2020's	12 (35.29)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Publication Type	This drug (%)	All Drugs (%)
Trials	0 (0.00%)	5.53%
Reviews	3 (8.57%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	32 (91.43%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Relationship Strength	Studies	Classes	Roles
gamma-aminobutyric acid gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.. gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.	2.53	2	amino acid zwitterion; gamma-amino acid; monocarboxylic acid	human metabolite; neurotransmitter; Saccharomyces cerevisiae metabolite; signalling molecule
acetic acid Acetic Acid: Product of the oxidation of ethanol and of the destructive distillation of wood. It is used locally, occasionally internally, as a counterirritant and also as a reagent. (Stedman, 26th ed). acetic acid : A simple monocarboxylic acid containing two carbons.	7.21	1	monocarboxylic acid	antimicrobial food preservative; Daphnia magna metabolite; food acidity regulator; protic solvent
phloroglucinol Phloroglucinol: A trinitrobenzene derivative with antispasmodic properties that is used primarily as a laboratory reagent.. phloroglucinol : A benzenetriol with hydroxy groups at position 1, 3 and 5.	2.08	1	benzenetriol; phenolic donor	algal metabolite
palmitic acid Palmitic Acid: A common saturated fatty acid found in fats and waxes including olive oil, palm oil, and body lipids.. hexadecanoic acid : A straight-chain, sixteen-carbon, saturated long-chain fatty acid.	2.05	1	long-chain fatty acid; straight-chain saturated fatty acid	algal metabolite; Daphnia magna metabolite; EC 1.1.1.189 (prostaglandin-E2 9-reductase) inhibitor; plant metabolite
eucalyptol [no description available]	2.1	1
flumazenil Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.. flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.	2.1	1	ethyl ester; imidazobenzodiazepine; organofluorine compound	antidote to benzodiazepine poisoning; GABA antagonist
linalool linalool: RN given refers to parent cpd without isomeric designation; structure. linalool : A monoterpenoid that is octa-1,6-diene substituted by methyl groups at positions 3 and 7 and a hydroxy group at position 3. It has been isolated from plants like Ocimum canum.	2.77	3	monoterpenoid; tertiary alcohol	antimicrobial agent; fragrance; plant metabolite; volatile oil component
alpha-pinene [no description available]	2.87	3	pinene	plant metabolite
thymol Thymol: A phenol obtained from thyme oil or other volatile oils used as a stabilizer in pharmaceutical preparations, and as an antiseptic (antibacterial or antifungal) agent.. thymol : A phenol that is a natural monoterpene derivative of cymene.	2.1	1	monoterpenoid; phenols	volatile oil component
carvone carvone: an oxidized derivative of limonene; RN given refers to cpd without isomeric designation; L-carvone has spearmint flavor, D-carvone has dill/caraway flavor. carvone : A p-menthane monoterpenoid that consists of cyclohex-2-enone having methyl and isopropenyl substituents at positions 2 and 5, respectively.	2.08	1	botanical anti-fungal agent; carvones	allergen
4-cymene 4-cymene: structure. p-cymene : A monoterpene that is toluene substituted by an isopropyl group at position 4.	2.1	1	monoterpene; toluenes	human urinary metabolite; plant metabolite; volatile oil component
cyclohexanol Cyclohexanols: Monohydroxy derivatives of cyclohexanes that contain the general formula R-C6H11O. They have a camphorlike odor and are used in making soaps, insecticides, germicides, dry cleaning, and plasticizers.. cyclohexanols : An alcohol in which one or more hydroxy groups are attached to a cyclohexane skeleton.	2.1	1	cyclohexanols; secondary alcohol	solvent
1-hexanol 1-hexanol: RN given refers to parent cpd. hexanol : A fatty alcohol consisting of a hydroxy function at any position of an unbranched saturated chain of six carbon atoms.. hexan-1-ol : A primary alcohol that is hexane substituted by a hydroxy group at position 1.	2.05	1	hexanol; primary alcohol	alarm pheromone; antibacterial agent; fragrance; plant metabolite
estragole estragole : A phenylpropanoid that is chavicol in which the hydroxy group is replaced by a methoxy group.	2.1	1	alkenylbenzene; monomethoxybenzene; phenylpropanoid	carcinogenic agent; flavouring agent; genotoxin; insect attractant; plant metabolite
phloroglucinol dimethyl ether phloroglucinol dimethyl ether: structure	2.08	1	methoxybenzenes; phenols
3-hexen-1-ol 3-hexen-1-ol: RN given refers to (Z)-isomer; a green odor chemical. hex-3-en-1-ol : A primary alcohol that is hex-3-ene substituted by a hydroxy group at position 1.	2.05	1	alkenyl alcohol; homoallylic alcohol; primary alcohol; volatile organic compound	plant metabolite
beta-pinene beta-pinene: alpha-pinene is also available. beta-pinene : An isomer of pinene with an exocyclic double bond. It is a component of essential oils from many plants.	2.1	1	pinene	plant metabolite
alpha-terpineol terpineol : A family of monoterpenols that have a p-menthane skeleton containing one double bond and bearing a single hydroxy substituent.	2.8	3	terpineol	plant metabolite
sabinene sabinene: RN given refers to cpd without isomeric designation. sabinene : A thujene that is a bicyclic monoterpene isolated from the essential oils of various plant species.	2.63	2	thujene	plant metabolite
1-octen-3-ol 1-octen-3-ol: main flavor component of mushrooms; RN given refers to cpd without isomeric designation; bait for insect vectors (tsetse, sandflies, mosquitoes). oct-1-en-3-ol : An alkenyl alcohol with a structure based on a C8 unbranched chain with the hydroxy group at C-2 and unsaturation at C-1-C-2. It is a major volatile compound present in many mushrooms and fungi.	7.08	1	alkenyl alcohol; medium-chain fatty alcohol	antimicrobial agent; fungal metabolite; insect attractant; volatile oil component
dihydrocarvone dihydrocarvone: found in caraway oil; structure in first source. dihydrocarvone : A dihydrocarvone resulting from reduction of the endocyclic cyclohexene double bond.	2.08	1	dihydrocarvones	plant metabolite
verbenone verbenone: platelet aggregation inhibitor; RN given refers to cpd without isomeric designation. 4,6,6-trimethylbicyclo[3.1.1]hept-3-en-2-one : A carbobicyclic compound that is bicyclo[3.1.1]heptane which is substituted by an oxo group at position 2 and by methyl groups at positions 4, 6 and 6, and which contains a double bond between positions 3 and 4.. (S)-(-)-verbenone : A 4,6,6-trimethylbicyclo[3.1.1]hept-3-en-2-one in which both chiral centres have S configuration.	2.11	1	carbobicyclic compound; cyclic ketone; enone
phenyl acetate phenyl acetate: The ester formed between phenol and acetic acid. Don't confuse with phenylacetic acid derivatives listed under PHENYLACETATES.. phenyl acetate : An acetate ester obtained by the formal condensation of phenol with acetic acid.	2.05	1	benzenes; phenyl acetates
myrcene myrcene: structure in first source. beta-myrcene : A monoterpene that is octa-1,6-diene bearing methylene and methyl substituents at positions 3 and 7 respectively.	2.57	2	monoterpene	anabolic agent; anti-inflammatory agent; flavouring agent; fragrance; plant metabolite; volatile oil component
nonanal nonanal : A saturated fatty aldehyde formally arising from reduction of the carboxy group of nonanoic acid. Metabolite observed in cancer metabolism.	2.05	1	medium-chain fatty aldehyde; n-alkanal; saturated fatty aldehyde	human metabolite; plant metabolite
verbenol verbenol: RN given refers to cpd with unspecified isomeric designation; structure	3.51	7	monoterpenoid
myrtenal myrtenal: RN refers to cpd without isomeric designation; structure given in first source	7.8	3
beta-thujone [no description available]	2.1	1	beta-thujone
6,6-dimethyl-2-methylenebicyclo(3.1.1)heptan-3-ol 6,6-dimethyl-2-methylenebicyclo(3.1.1)heptan-3-ol: fragrance ingredient; structure in first source. pinocarveol : A pinane monoterpenoid that is a bicyclo[3.1.1]heptane substituted by two methyl groups at position 6, a methylidene group at position 2 and a hydroxy group at position 3.	2.1	1	carbobicyclic compound; pinane monoterpenoid; secondary alcohol	GABA modulator; mouse metabolite; plant metabolite; volatile oil component
brevicomin brevicomin: RN given refers to (1R-exo)-isomer; structure	2.04	1
perillyl alcohol (S)-(-)-perillyl alcohol : A perillyl alcohol in which the chiral centre has S configuration.	2.04	1	perillyl alcohol
betadex beta-Cyclodextrins: Cyclic GLUCANS consisting of seven (7) glucopyranose units linked by 1,4-glycosidic bonds.	2.25	1	cyclodextrin
chavibetol chavibetol: isolated from essential oil of Pimenta pseudocaryophyllus leaf; structure in first source	2.1	1	methoxybenzenes; phenols
geraniol [no description available]	2.04	1	3,7-dimethylocta-2,6-dien-1-ol; monoterpenoid; primary alcohol	allergen; fragrance; plant metabolite; volatile oil component
glycosides [no description available]	7.08	1
citral citral: Xref geranial: geraniol is also available; Xref neral: nerol is also available; vitamin A antagonist; oxygenated monoterpene; inhibits cytosolic dehydrogenases; structure. citral : An enal that consists of octa-2,6-dienal bearing methyl substituents at positions 3 and 7. A mixture of the two geometric isomers geranial and neral, it is the major constituent (75-85%) of oil of lemon grass, the volatile oil of Cymbopogon citratus, or of C. flexuosus. It also occurs in oils of verbena, lemon, and orange.	2.17	1	enal; monoterpenoid; polyprenal	plant metabolite; volatile oil component
nerol nerol : The (2Z)-stereoisomer of 3,7-dimethylocta-2,6-dien-1-ol. It has been isolated from the essential oils from plants like lemon grass.	2.04	1	3,7-dimethylocta-2,6-dien-1-ol	fragrance; plant metabolite; volatile oil component
ovalbumin Ovalbumin: An albumin obtained from the white of eggs. It is a member of the serpin superfamily.	2.6	1
pulmicort Budesonide: A glucocorticoid used in the management of ASTHMA, the treatment of various skin disorders, and allergic RHINITIS.. budesonide : A glucocorticoid steroid having a highly oxygenated pregna-1,4-diene structure. It is used mainly in the treatment of asthma and non-infectious rhinitis and for treatment and prevention of nasal polyposis.	2.6	1	11beta-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(1),Delta(4)-steroid; cyclic acetal; glucocorticoid; primary alpha-hydroxy ketone	anti-inflammatory drug; bronchodilator agent; drug allergen
isoborneol isoborneol: RN given refers to cpd without isomeric designation; structure	2.1	1	borneol
mocetinostat mocetinostat: undergoing phase II clinical trials for treatment of cancer. mocetinostat : A benzamide obtained by formal condensation of the carboxy group of 4-({[4-(pyridin-3-yl)pyrimidin-2-yl]amino}methyl)benzoic acid with one of the amino groups of benzene-1,2-diamine. It is an orally active and isotype-selective HDAC inhibitor which exhibits antitumour activity (IC50 = 0.15, 0.29, 1.66 and 0.59 muM for HDAC1, HDAC2, HDAC3 and HDAC11).	2.13	1	aminopyrimidine; benzamides; pyridines; secondary amino compound; secondary carboxamide; substituted aniline	antineoplastic agent; apoptosis inducer; autophagy inducer; cardioprotective agent; EC 3.5.1.98 (histone deacetylase) inhibitor; hepatotoxic agent
frontalin [no description available]	2.04	1

Condition	Relationship Strength	Studies
Arthritis, Degenerative [description not available]	2.1	1
Osteoarthritis A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans.	2.1	1
Alloxan Diabetes [description not available]	2.31	1
Innate Inflammatory Response [description not available]	2.31	1
Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.	7.31	1
Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.	2.31	1
Encephalopathy, Traumatic [description not available]	2.6	1
Acute Brain Injuries [description not available]	2.6	1
Coma A profound state of unconsciousness associated with depressed cerebral activity from which the individual cannot be aroused. Coma generally occurs when there is dysfunction or injury involving both cerebral hemispheres or the brain stem RETICULAR FORMATION.	2.6	1
Brain Injuries, Traumatic A form of acquired brain injury which occurs when a sudden trauma causes damage to the brain.	2.6	1
Brain Injuries Acute and chronic (see also BRAIN INJURIES, CHRONIC) injuries to the brain, including the cerebral hemispheres, CEREBELLUM, and BRAIN STEM. Clinical manifestations depend on the nature of injury. Diffuse trauma to the brain is frequently associated with DIFFUSE AXONAL INJURY or COMA, POST-TRAUMATIC. Localized injuries may be associated with NEUROBEHAVIORAL MANIFESTATIONS; HEMIPARESIS, or other focal neurologic deficits.	2.6	1
Asthma, Bronchial [description not available]	2.6	1
Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.	2.66	2
Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).	7.6	1
Nociceptive Pain Dull or sharp aching pain caused by stimulated NOCICEPTORS due to tissue injury, inflammation or diseases. It can be divided into somatic or tissue pain and VISCERAL PAIN.	2.25	1
Pain, Chronic [description not available]	2.25	1
Cognitive Decline [description not available]	2.25	1
Diffuse Myofascial Pain Syndrome [description not available]	2.25	1
Allodynia [description not available]	2.25	1
Fibromyalgia A common nonarticular rheumatic syndrome characterized by myalgia and multiple points of focal muscle tenderness to palpation (trigger points). Muscle pain is typically aggravated by inactivity or exposure to cold. This condition is often associated with general symptoms, such as sleep disturbances, fatigue, stiffness, HEADACHES, and occasionally DEPRESSION. There is significant overlap between fibromyalgia and the chronic fatigue syndrome (FATIGUE SYNDROME, CHRONIC). Fibromyalgia may arise as a primary or secondary disease process. It is most frequent in females aged 20 to 50 years. (From Adams et al., Principles of Neurology, 6th ed, p1494-95)	2.25	1
Chronic Pain Aching sensation that persists for more than a few months. It may or may not be associated with trauma or disease, and may persist after the initial injury has healed. Its localization, character, and timing are more vague than with acute pain.	2.25	1
Musculoskeletal Pain Discomfort stemming from muscles, LIGAMENTS, tendons, and bones.	7.25	1
Cognitive Dysfunction Diminished or impaired mental and/or intellectual function.	2.25	1
Anterior Choroidal Artery Infarction [description not available]	2.31	1
Injury, Ischemia-Reperfusion [description not available]	2.31	1
Cerebral Infarction The formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic infarction).	7.31	1
Reperfusion Injury Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.	2.31	1
Adjuvant Arthritis [description not available]	2.15	1
Injury, Myocardial Reperfusion [description not available]	2.17	1
Adenocarcinoma, Basal Cell [description not available]	2.21	1
Cancer of Stomach [description not available]	2.21	1
Gastric Ulcer [description not available]	7.57	2
Adenocarcinoma A malignant epithelial tumor with a glandular organization.	7.21	1
Stomach Neoplasms Tumors or cancer of the STOMACH.	2.21	1
Stomach Ulcer Ulceration of the GASTRIC MUCOSA due to contact with GASTRIC JUICE. It is often associated with HELICOBACTER PYLORI infection or consumption of nonsteroidal anti-inflammatory drugs (NSAIDS).	2.57	2
Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)	2.08	1

myrtenol

Description

Cross-References

Synonyms (45)

Research Excerpts

Overview

Effects

Treatment

Pathways (1)

Bioassays (5)

Research

Studies (34)

Market Indicators

Research Demand Index: 35.50

Study Types